EUVIMEDOpdag EUVIMED
Crossref

Bone marrow mesenchymal stem cells with low dose bone morphogenetic protein 2 enhances scaffold‐based spinal fusion in a porcine model

Tao Hu, Ling Liu iD, Raymond Wing Moon Lam, Soo Yein Toh, Sunny Akogwu Abbah, Ming Wang, Amit Kumarsing Ramruttun, Kishore Bhakoo, Simon Cool, Jun Li iD, James Cho-Hong Goh, Hee-Kit Wong

Journal of Tissue Engineering and Regenerative Medicine · 2022-01 · 16 (1) · 63-75

DOI: 10.1002/term.3260 ↗

At a glance

Journal article in Journal of Tissue Engineering and Regenerative Medicine, 2021-11. Written by Tao Hu and 11 co-authors. Institution: Department of Orthopaedic Surgery, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore. Major MEDLINE topics: Mesenchymal Stem Cells, Spinal Fusion. Cited 10 times so far (Crossref); 46 references. Funded by: Shanghai East Hospital Xuri Young Excellent Talents Program, Key Discipline Construction Project of Pudong Health Bureau of Shanghai, ASTAR BMRC.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Intet abstract tilgængeligt.

Subjects

MeSH terms (MEDLINE)

Mesenchymal Stem CellsSpinal FusionAnimalsBone Morphogenetic Protein 2Bone RegenerationModels, AnimalSwineTransforming Growth Factor beta

Author keywords

bone marrow mesenchymal stem cellsbone regenerationlow dose BMP-2polyelectrolyte complexspinal fusion

Substances

Bone Morphogenetic Protein 2Transforming Growth Factor beta

Authors and institutions

  • Department of Orthopaedic Surgery, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
  • Department of Spine Surgery, Tongji University School of Medicine, Shanghai East Hospital, Shanghai, China.
  • Department of Biomedical Engineering, Faculty of Engineering, National University of Singapore, Singapore, Singapore.
  • Department of Obstetrics and Gynaecology, Portiuncula University Hospital Ballinasloe, Galway, Ireland.
  • CÚRAM, Centre for Research in Medical Devices, National University of Ireland, Galway, Ireland.
  • Singapore Bioimaging Consortium, Agency for Science, Technology and Research (A*STAR), Singapore, Singapore.

ORCID profiles: Ling Liu, Jun Li

Funding

  • Shanghai East Hospital Xuri Young Excellent Talents Program
  • Key Discipline Construction Project of Pudong Health Bureau of Shanghai
  • ASTAR BMRC
  • National Natural Science Foundation of China

Cite

APA

Hu, T., Liu, L., Lam, R. W. M., Toh, S. Y., Abbah, S. A., Wang, M., Ramruttun, A. K., Bhakoo, K., Cool, S., Li, J., Cho-Hong Goh, J., & Wong, H. K. (2022). Bone marrow mesenchymal stem cells with low dose bone morphogenetic protein 2 enhances scaffold‐based spinal fusion in a porcine model. Journal of Tissue Engineering and Regenerative Medicine, 16(1), 63-75. https://doi.org/10.1002/term.3260

Vancouver

Hu T, Liu L, Lam RWM, Toh SY, Abbah SA, Wang M, et al. Bone marrow mesenchymal stem cells with low dose bone morphogenetic protein 2 enhances scaffold‐based spinal fusion in a porcine model. Journal of Tissue Engineering and Regenerative Medicine. 2022;16(1):63-75. doi:10.1002/term.3260

BibTeX
@article{Hu2022,
  author = {Hu, Tao and Liu, Ling and Lam, Raymond Wing Moon and Toh, Soo Yein and Abbah, Sunny Akogwu and Wang, Ming and Ramruttun, Amit Kumarsing and Bhakoo, Kishore and Cool, Simon and Li, Jun and Cho-Hong Goh, James and Wong, Hee-Kit},
  title = {Bone marrow mesenchymal stem cells with low dose bone morphogenetic protein 2 enhances scaffold‐based spinal fusion in a porcine model},
  journal = {Journal of Tissue Engineering and Regenerative Medicine},
  year = {2022},
  volume = {16},
  number = {1},
  pages = {63--75},
  doi = {10.1002/term.3260}
}
Start for free →